img

Global Long-acting Injectable Medications Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Long-acting Injectable Medications Market Insights, Forecast to 2034

Long-acting injectables (LAIs) are unique tools used in psychiatric pharmacy to help improve patient outcomes. They offer a number of benefits compared to oral therapy, including confirmed patient adherence, consistent drug delivery, predictable bioavailability and prevention of antipsychotic overdoses. Its origins in indications such as schizophrenia and contraception, also HIV treatment and prevention.
Market Analysis and InsightsGlobal Long-acting Injectable Medications Market
Global Long-acting Injectable Medications market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Long-acting Injectable Medications industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Long-acting Injectable Medications market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Long-acting Injectable Medications market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Eli Lilly
Alkermes
Johnson & Johnson
Zogenix
DURECT
Mapi Pharma
GSK
MedinCell
Oakwood Labs
Nanomi
Pharmathen
Kashiv BioSciences
Segment by Type
First-generation
Second-generation

Segment by Application


Schizophrenia
Contraception
HIV
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Long-acting Injectable Medications introduction, etc. Long-acting Injectable Medications Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Long-acting Injectable Medications
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Long-acting Injectable Medications Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 First-generation
1.2.3 Second-generation
1.3 Market by Application
1.3.1 Global Long-acting Injectable Medications Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Schizophrenia
1.3.3 Contraception
1.3.4 HIV
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Long-acting Injectable Medications Market Perspective (2018-2033)
2.2 Global Long-acting Injectable Medications Growth Trends by Region
2.2.1 Long-acting Injectable Medications Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Long-acting Injectable Medications Historic Market Size by Region (2018-2023)
2.2.3 Long-acting Injectable Medications Forecasted Market Size by Region (2024-2033)
2.3 Long-acting Injectable Medications Market Dynamics
2.3.1 Long-acting Injectable Medications Industry Trends
2.3.2 Long-acting Injectable Medications Market Drivers
2.3.3 Long-acting Injectable Medications Market Challenges
2.3.4 Long-acting Injectable Medications Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Long-acting Injectable Medications by Players
3.1.1 Global Long-acting Injectable Medications Revenue by Players (2018-2023)
3.1.2 Global Long-acting Injectable Medications Revenue Market Share by Players (2018-2023)
3.2 Global Long-acting Injectable Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Long-acting Injectable Medications, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Long-acting Injectable Medications Market Concentration Ratio
3.4.1 Global Long-acting Injectable Medications Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Long-acting Injectable Medications Revenue in 2022
3.5 Global Key Players of Long-acting Injectable Medications Head office and Area Served
3.6 Global Key Players of Long-acting Injectable Medications, Product and Application
3.7 Global Key Players of Long-acting Injectable Medications, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Long-acting Injectable Medications Breakdown Data by Type
4.1 Global Long-acting Injectable Medications Historic Market Size by Type (2018-2023)
4.2 Global Long-acting Injectable Medications Forecasted Market Size by Type (2024-2033)
5 Long-acting Injectable Medications Breakdown Data by Application
5.1 Global Long-acting Injectable Medications Historic Market Size by Application (2018-2023)
5.2 Global Long-acting Injectable Medications Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Long-acting Injectable Medications Market Size (2018-2033)
6.2 North America Long-acting Injectable Medications Market Size by Type
6.2.1 North America Long-acting Injectable Medications Market Size by Type (2018-2023)
6.2.2 North America Long-acting Injectable Medications Market Size by Type (2024-2033)
6.2.3 North America Long-acting Injectable Medications Market Share by Type (2018-2033)
6.3 North America Long-acting Injectable Medications Market Size by Application
6.3.1 North America Long-acting Injectable Medications Market Size by Application (2018-2023)
6.3.2 North America Long-acting Injectable Medications Market Size by Application (2024-2033)
6.3.3 North America Long-acting Injectable Medications Market Share by Application (2018-2033)
6.4 North America Long-acting Injectable Medications Market Size by Country
6.4.1 North America Long-acting Injectable Medications Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Long-acting Injectable Medications Market Size by Country (2018-2023)
6.4.3 North America Long-acting Injectable Medications Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Long-acting Injectable Medications Market Size (2018-2033)
7.2 Europe Long-acting Injectable Medications Market Size by Type
7.2.1 Europe Long-acting Injectable Medications Market Size by Type (2018-2023)
7.2.2 Europe Long-acting Injectable Medications Market Size by Type (2024-2033)
7.2.3 Europe Long-acting Injectable Medications Market Share by Type (2018-2033)
7.3 Europe Long-acting Injectable Medications Market Size by Application
7.3.1 Europe Long-acting Injectable Medications Market Size by Application (2018-2023)
7.3.2 Europe Long-acting Injectable Medications Market Size by Application (2024-2033)
7.3.3 Europe Long-acting Injectable Medications Market Share by Application (2018-2033)
7.4 Europe Long-acting Injectable Medications Market Size by Country
7.4.1 Europe Long-acting Injectable Medications Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Long-acting Injectable Medications Market Size by Country (2018-2023)
7.4.3 Europe Long-acting Injectable Medications Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Long-acting Injectable Medications Market Size (2018-2033)
8.2 China Long-acting Injectable Medications Market Size by Type
8.2.1 China Long-acting Injectable Medications Market Size by Type (2018-2023)
8.2.2 China Long-acting Injectable Medications Market Size by Type (2024-2033)
8.2.3 China Long-acting Injectable Medications Market Share by Type (2018-2033)
8.3 China Long-acting Injectable Medications Market Size by Application
8.3.1 China Long-acting Injectable Medications Market Size by Application (2018-2023)
8.3.2 China Long-acting Injectable Medications Market Size by Application (2024-2033)
8.3.3 China Long-acting Injectable Medications Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Long-acting Injectable Medications Market Size (2018-2033)
9.2 Asia Long-acting Injectable Medications Market Size by Type
9.2.1 Asia Long-acting Injectable Medications Market Size by Type (2018-2023)
9.2.2 Asia Long-acting Injectable Medications Market Size by Type (2024-2033)
9.2.3 Asia Long-acting Injectable Medications Market Share by Type (2018-2033)
9.3 Asia Long-acting Injectable Medications Market Size by Application
9.3.1 Asia Long-acting Injectable Medications Market Size by Application (2018-2023)
9.3.2 Asia Long-acting Injectable Medications Market Size by Application (2024-2033)
9.3.3 Asia Long-acting Injectable Medications Market Share by Application (2018-2033)
9.4 Asia Long-acting Injectable Medications Market Size by Region
9.4.1 Asia Long-acting Injectable Medications Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Long-acting Injectable Medications Market Size by Region (2018-2023)
9.4.3 Asia Long-acting Injectable Medications Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Long-acting Injectable Medications Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Long-acting Injectable Medications Market Size by Type
10.2.1 Middle East, Africa, and Latin America Long-acting Injectable Medications Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Long-acting Injectable Medications Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Long-acting Injectable Medications Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Long-acting Injectable Medications Market Size by Application
10.3.1 Middle East, Africa, and Latin America Long-acting Injectable Medications Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Long-acting Injectable Medications Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Long-acting Injectable Medications Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Long-acting Injectable Medications Market Size by Country
10.4.1 Middle East, Africa, and Latin America Long-acting Injectable Medications Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Long-acting Injectable Medications Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Long-acting Injectable Medications Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Details
11.1.2 Eli Lilly Business Overview
11.1.3 Eli Lilly Long-acting Injectable Medications Introduction
11.1.4 Eli Lilly Revenue in Long-acting Injectable Medications Business (2018-2023)
11.1.5 Eli Lilly Recent Developments
11.2 Alkermes
11.2.1 Alkermes Company Details
11.2.2 Alkermes Business Overview
11.2.3 Alkermes Long-acting Injectable Medications Introduction
11.2.4 Alkermes Revenue in Long-acting Injectable Medications Business (2018-2023)
11.2.5 Alkermes Recent Developments
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Long-acting Injectable Medications Introduction
11.3.4 Johnson & Johnson Revenue in Long-acting Injectable Medications Business (2018-2023)
11.3.5 Johnson & Johnson Recent Developments
11.4 Zogenix
11.4.1 Zogenix Company Details
11.4.2 Zogenix Business Overview
11.4.3 Zogenix Long-acting Injectable Medications Introduction
11.4.4 Zogenix Revenue in Long-acting Injectable Medications Business (2018-2023)
11.4.5 Zogenix Recent Developments
11.5 DURECT
11.5.1 DURECT Company Details
11.5.2 DURECT Business Overview
11.5.3 DURECT Long-acting Injectable Medications Introduction
11.5.4 DURECT Revenue in Long-acting Injectable Medications Business (2018-2023)
11.5.5 DURECT Recent Developments
11.6 Mapi Pharma
11.6.1 Mapi Pharma Company Details
11.6.2 Mapi Pharma Business Overview
11.6.3 Mapi Pharma Long-acting Injectable Medications Introduction
11.6.4 Mapi Pharma Revenue in Long-acting Injectable Medications Business (2018-2023)
11.6.5 Mapi Pharma Recent Developments
11.7 GSK
11.7.1 GSK Company Details
11.7.2 GSK Business Overview
11.7.3 GSK Long-acting Injectable Medications Introduction
11.7.4 GSK Revenue in Long-acting Injectable Medications Business (2018-2023)
11.7.5 GSK Recent Developments
11.8 MedinCell
11.8.1 MedinCell Company Details
11.8.2 MedinCell Business Overview
11.8.3 MedinCell Long-acting Injectable Medications Introduction
11.8.4 MedinCell Revenue in Long-acting Injectable Medications Business (2018-2023)
11.8.5 MedinCell Recent Developments
11.9 Oakwood Labs
11.9.1 Oakwood Labs Company Details
11.9.2 Oakwood Labs Business Overview
11.9.3 Oakwood Labs Long-acting Injectable Medications Introduction
11.9.4 Oakwood Labs Revenue in Long-acting Injectable Medications Business (2018-2023)
11.9.5 Oakwood Labs Recent Developments
11.10 Nanomi
11.10.1 Nanomi Company Details
11.10.2 Nanomi Business Overview
11.10.3 Nanomi Long-acting Injectable Medications Introduction
11.10.4 Nanomi Revenue in Long-acting Injectable Medications Business (2018-2023)
11.10.5 Nanomi Recent Developments
11.11 Pharmathen
11.11.1 Pharmathen Company Details
11.11.2 Pharmathen Business Overview
11.11.3 Pharmathen Long-acting Injectable Medications Introduction
11.11.4 Pharmathen Revenue in Long-acting Injectable Medications Business (2018-2023)
11.11.5 Pharmathen Recent Developments
11.12 Kashiv BioSciences
11.12.1 Kashiv BioSciences Company Details
11.12.2 Kashiv BioSciences Business Overview
11.12.3 Kashiv BioSciences Long-acting Injectable Medications Introduction
11.12.4 Kashiv BioSciences Revenue in Long-acting Injectable Medications Business (2018-2023)
11.12.5 Kashiv BioSciences Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Long-acting Injectable Medications Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of First-generation
Table 3. Key Players of Second-generation
Table 4. Global Long-acting Injectable Medications Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 5. Global Long-acting Injectable Medications Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Long-acting Injectable Medications Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Long-acting Injectable Medications Market Share by Region (2018-2023)
Table 8. Global Long-acting Injectable Medications Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Long-acting Injectable Medications Market Share by Region (2024-2033)
Table 10. Long-acting Injectable Medications Market Trends
Table 11. Long-acting Injectable Medications Market Drivers
Table 12. Long-acting Injectable Medications Market Challenges
Table 13. Long-acting Injectable Medications Market Restraints
Table 14. Global Long-acting Injectable Medications Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Long-acting Injectable Medications Revenue Share by Players (2018-2023)
Table 16. Global Top Long-acting Injectable Medications by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long-acting Injectable Medications as of 2022)
Table 17. Global Long-acting Injectable Medications Industry Ranking 2021 VS 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by Long-acting Injectable Medications Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of Long-acting Injectable Medications, Headquarters and Area Served
Table 20. Global Key Players of Long-acting Injectable Medications, Product and Application
Table 21. Global Key Players of Long-acting Injectable Medications, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Long-acting Injectable Medications Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Long-acting Injectable Medications Revenue Market Share by Type (2018-2023)
Table 25. Global Long-acting Injectable Medications Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Long-acting Injectable Medications Revenue Market Share by Type (2024-2033)
Table 27. Global Long-acting Injectable Medications Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Long-acting Injectable Medications Revenue Share by Application (2018-2023)
Table 29. Global Long-acting Injectable Medications Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Long-acting Injectable Medications Revenue Share by Application (2024-2033)
Table 31. North America Long-acting Injectable Medications Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America Long-acting Injectable Medications Market Size by Type (2024-2033) & (US$ Million)
Table 33. North America Long-acting Injectable Medications Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America Long-acting Injectable Medications Market Size by Application (2024-2033) & (US$ Million)
Table 35. North America Long-acting Injectable Medications Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. North America Long-acting Injectable Medications Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Long-acting Injectable Medications Market Size by Country (2024-2033) & (US$ Million)
Table 38. Europe Long-acting Injectable Medications Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe Long-acting Injectable Medications Market Size by Type (2024-2033) & (US$ Million)
Table 40. Europe Long-acting Injectable Medications Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe Long-acting Injectable Medications Market Size by Application (2024-2033) & (US$ Million)
Table 42. Europe Long-acting Injectable Medications Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Europe Long-acting Injectable Medications Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe Long-acting Injectable Medications Market Size by Country (2024-2033) & (US$ Million)
Table 45. China Long-acting Injectable Medications Market Size by Type (2018-2023) & (US$ Million)
Table 46. China Long-acting Injectable Medications Market Size by Type (2024-2033) & (US$ Million)
Table 47. China Long-acting Injectable Medications Market Size by Application (2018-2023) & (US$ Million)
Table 48. China Long-acting Injectable Medications Market Size by Application (2024-2033) & (US$ Million)
Table 49. Asia Long-acting Injectable Medications Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia Long-acting Injectable Medications Market Size by Type (2024-2033) & (US$ Million)
Table 51. Asia Long-acting Injectable Medications Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia Long-acting Injectable Medications Market Size by Application (2024-2033) & (US$ Million)
Table 53. Asia Long-acting Injectable Medications Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 54. Asia Long-acting Injectable Medications Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia Long-acting Injectable Medications Market Size by Region (2024-2033) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Long-acting Injectable Medications Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Long-acting Injectable Medications Market Size by Type (2024-2033) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Long-acting Injectable Medications Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Long-acting Injectable Medications Market Size by Application (2024-2033) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Long-acting Injectable Medications Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 61. Middle East, Africa, and Latin America Long-acting Injectable Medications Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Long-acting Injectable Medications Market Size by Country (2024-2033) & (US$ Million)
Table 63. Eli Lilly Company Details
Table 64. Eli Lilly Business Overview
Table 65. Eli Lilly Long-acting Injectable Medications Product
Table 66. Eli Lilly Revenue in Long-acting Injectable Medications Business (2018-2023) & (US$ Million)
Table 67. Eli Lilly Recent Developments
Table 68. Alkermes Company Details
Table 69. Alkermes Business Overview
Table 70. Alkermes Long-acting Injectable Medications Product
Table 71. Alkermes Revenue in Long-acting Injectable Medications Business (2018-2023) & (US$ Million)
Table 72. Alkermes Recent Developments
Table 73. Johnson & Johnson Company Details
Table 74. Johnson & Johnson Business Overview
Table 75. Johnson & Johnson Long-acting Injectable Medications Product
Table 76. Johnson & Johnson Revenue in Long-acting Injectable Medications Business (2018-2023) & (US$ Million)
Table 77. Johnson & Johnson Recent Developments
Table 78. Zogenix Company Details
Table 79. Zogenix Business Overview
Table 80. Zogenix Long-acting Injectable Medications Product
Table 81. Zogenix Revenue in Long-acting Injectable Medications Business (2018-2023) & (US$ Million)
Table 82. Zogenix Recent Developments
Table 83. DURECT Company Details
Table 84. DURECT Business Overview
Table 85. DURECT Long-acting Injectable Medications Product
Table 86. DURECT Revenue in Long-acting Injectable Medications Business (2018-2023) & (US$ Million)
Table 87. DURECT Recent Developments
Table 88. Mapi Pharma Company Details
Table 89. Mapi Pharma Business Overview
Table 90. Mapi Pharma Long-acting Injectable Medications Product
Table 91. Mapi Pharma Revenue in Long-acting Injectable Medications Business (2018-2023) & (US$ Million)
Table 92. Mapi Pharma Recent Developments
Table 93. GSK Company Details
Table 94. GSK Business Overview
Table 95. GSK Long-acting Injectable Medications Product
Table 96. GSK Revenue in Long-acting Injectable Medications Business (2018-2023) & (US$ Million)
Table 97. GSK Recent Developments
Table 98. MedinCell Company Details
Table 99. MedinCell Business Overview
Table 100. MedinCell Long-acting Injectable Medications Product
Table 101. MedinCell Revenue in Long-acting Injectable Medications Business (2018-2023) & (US$ Million)
Table 102. MedinCell Recent Developments
Table 103. Oakwood Labs Company Details
Table 104. Oakwood Labs Business Overview
Table 105. Oakwood Labs Long-acting Injectable Medications Product
Table 106. Oakwood Labs Revenue in Long-acting Injectable Medications Business (2018-2023) & (US$ Million)
Table 107. Oakwood Labs Recent Developments
Table 108. Nanomi Company Details
Table 109. Nanomi Business Overview
Table 110. Nanomi Long-acting Injectable Medications Product
Table 111. Nanomi Revenue in Long-acting Injectable Medications Business (2018-2023) & (US$ Million)
Table 112. Nanomi Recent Developments
Table 113. Pharmathen Company Details
Table 114. Pharmathen Business Overview
Table 115. Pharmathen Long-acting Injectable Medications Product
Table 116. Pharmathen Revenue in Long-acting Injectable Medications Business (2018-2023) & (US$ Million)
Table 117. Pharmathen Recent Developments
Table 118. Kashiv BioSciences Company Details
Table 119. Kashiv BioSciences Business Overview
Table 120. Kashiv BioSciences Long-acting Injectable Medications Product
Table 121. Kashiv BioSciences Revenue in Long-acting Injectable Medications Business (2018-2023) & (US$ Million)
Table 122. Kashiv BioSciences Recent Developments
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Long-acting Injectable Medications Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Long-acting Injectable Medications Market Share by Type: 2022 VS 2033
Figure 3. First-generation Features
Figure 4. Second-generation Features
Figure 5. Global Long-acting Injectable Medications Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 6. Global Long-acting Injectable Medications Market Share by Application: 2022 VS 2033
Figure 7. Schizophrenia Case Studies
Figure 8. Contraception Case Studies
Figure 9. HIV Case Studies
Figure 10. Others Case Studies
Figure 11. Long-acting Injectable Medications Report Years Considered
Figure 12. Global Long-acting Injectable Medications Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Long-acting Injectable Medications Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Long-acting Injectable Medications Market Share by Region: 2022 VS 2033
Figure 15. Global Long-acting Injectable Medications Market Share by Players in 2022
Figure 16. Global Top Long-acting Injectable Medications Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long-acting Injectable Medications as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Long-acting Injectable Medications Revenue in 2022
Figure 18. North America Long-acting Injectable Medications Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Long-acting Injectable Medications Market Share by Type (2018-2033)
Figure 20. North America Long-acting Injectable Medications Market Share by Application (2018-2033)
Figure 21. North America Long-acting Injectable Medications Market Share by Country (2018-2033)
Figure 22. United States Long-acting Injectable Medications Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Canada Long-acting Injectable Medications Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Long-acting Injectable Medications Market Size YoY (2018-2033) & (US$ Million)
Figure 25. Europe Long-acting Injectable Medications Market Share by Type (2018-2033)
Figure 26. Europe Long-acting Injectable Medications Market Share by Application (2018-2033)
Figure 27. Europe Long-acting Injectable Medications Market Share by Country (2018-2033)
Figure 28. Germany Long-acting Injectable Medications Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. France Long-acting Injectable Medications Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. U.K. Long-acting Injectable Medications Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Italy Long-acting Injectable Medications Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Russia Long-acting Injectable Medications Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Nordic Countries Long-acting Injectable Medications Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. China Long-acting Injectable Medications Market Size YoY (2018-2033) & (US$ Million)
Figure 35. China Long-acting Injectable Medications Market Share by Type (2018-2033)
Figure 36. China Long-acting Injectable Medications Market Share by Application (2018-2033)
Figure 37. Asia Long-acting Injectable Medications Market Size YoY (2018-2033) & (US$ Million)
Figure 38. Asia Long-acting Injectable Medications Market Share by Type (2018-2033)
Figure 39. Asia Long-acting Injectable Medications Market Share by Application (2018-2033)
Figure 40. Asia Long-acting Injectable Medications Market Share by Region (2018-2033)
Figure 41. Japan Long-acting Injectable Medications Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. South Korea Long-acting Injectable Medications Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. China Taiwan Long-acting Injectable Medications Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Southeast Asia Long-acting Injectable Medications Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. India Long-acting Injectable Medications Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Australia Long-acting Injectable Medications Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Long-acting Injectable Medications Market Size YoY (2018-2033) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Long-acting Injectable Medications Market Share by Type (2018-2033)
Figure 49. Middle East, Africa, and Latin America Long-acting Injectable Medications Market Share by Application (2018-2033)
Figure 50. Middle East, Africa, and Latin America Long-acting Injectable Medications Market Share by Country (2018-2033)
Figure 51. Brazil Long-acting Injectable Medications Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 52. Mexico Long-acting Injectable Medications Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Turkey Long-acting Injectable Medications Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Saudi Arabia Long-acting Injectable Medications Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Israel Long-acting Injectable Medications Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. GCC Countries Long-acting Injectable Medications Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. Eli Lilly Revenue Growth Rate in Long-acting Injectable Medications Business (2018-2023)
Figure 58. Alkermes Revenue Growth Rate in Long-acting Injectable Medications Business (2018-2023)
Figure 59. Johnson & Johnson Revenue Growth Rate in Long-acting Injectable Medications Business (2018-2023)
Figure 60. Zogenix Revenue Growth Rate in Long-acting Injectable Medications Business (2018-2023)
Figure 61. DURECT Revenue Growth Rate in Long-acting Injectable Medications Business (2018-2023)
Figure 62. Mapi Pharma Revenue Growth Rate in Long-acting Injectable Medications Business (2018-2023)
Figure 63. GSK Revenue Growth Rate in Long-acting Injectable Medications Business (2018-2023)
Figure 64. MedinCell Revenue Growth Rate in Long-acting Injectable Medications Business (2018-2023)
Figure 65. Oakwood Labs Revenue Growth Rate in Long-acting Injectable Medications Business (2018-2023)
Figure 66. Nanomi Revenue Growth Rate in Long-acting Injectable Medications Business (2018-2023)
Figure 67. Pharmathen Revenue Growth Rate in Long-acting Injectable Medications Business (2018-2023)
Figure 68. Kashiv BioSciences Revenue Growth Rate in Long-acting Injectable Medications Business (2018-2023)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries